These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 23781294)
21. Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies. Schaer DJ; Buehler PW Cold Spring Harb Perspect Med; 2013 Jun; 3(6):. PubMed ID: 23645855 [TBL] [Abstract][Full Text] [Related]
22. Sickle cell anemia and vascular dysfunction: the nitric oxide connection. Akinsheye I; Klings ES J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237 [TBL] [Abstract][Full Text] [Related]
23. Use of cysteine as a spectroscopic probe for determination of heme-scavenging capacity of serum proteins and whole human serum. Noé R; Bozinovic N; Lecerf M; Lacroix-Desmazes S; Dimitrov JD J Pharm Biomed Anal; 2019 Aug; 172():311-319. PubMed ID: 31085393 [TBL] [Abstract][Full Text] [Related]
24. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Gladwin MT; Kato GJ Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359 [TBL] [Abstract][Full Text] [Related]
25. [Heme-iron in the human body]. Balla J; Balla G; Lakatos B; Jeney V; Szentmihályi K Orv Hetil; 2007 Sep; 148(36):1699-706. PubMed ID: 17766221 [TBL] [Abstract][Full Text] [Related]
26. Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease. Vendrame F; Olops L; Saad STO; Costa FF; Fertrin KY J Clin Lipidol; 2018; 12(6):1532-1538. PubMed ID: 30219641 [TBL] [Abstract][Full Text] [Related]
27. Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation. Poillerat V; Gentinetta T; Leon J; Wassmer A; Edler M; Torset C; Luo D; Tuffin G; Roumenina LT Front Immunol; 2020; 11():1684. PubMed ID: 32849588 [TBL] [Abstract][Full Text] [Related]
28. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner. Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533 [TBL] [Abstract][Full Text] [Related]
29. New Insights into Hemopexin-Binding to Hemin and Hemoglobin. Lechuga GC; Napoleão-Pêgo P; Morel CM; Provance DW; De-Simone SG Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409149 [TBL] [Abstract][Full Text] [Related]
30. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351 [TBL] [Abstract][Full Text] [Related]
32. Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model. Tangudu NK; Alan B; Vinchi F; Wörle K; Lai D; Vettorazzi S; Leopold K; Vujić Spasić M Antioxid Redox Signal; 2018 Aug; 29(5):484-499. PubMed ID: 29212341 [TBL] [Abstract][Full Text] [Related]
33. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079 [TBL] [Abstract][Full Text] [Related]
34. Heme scavenging and the other facets of hemopexin. Tolosano E; Fagoonee S; Morello N; Vinchi F; Fiorito V Antioxid Redox Signal; 2010 Feb; 12(2):305-20. PubMed ID: 19650691 [TBL] [Abstract][Full Text] [Related]
35. Double-edged functions of hemopexin in hematological related diseases: from basic mechanisms to clinical application. Li Y; Chen R; Wang C; Deng J; Luo S Front Immunol; 2023; 14():1274333. PubMed ID: 38022615 [TBL] [Abstract][Full Text] [Related]
36. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Deuel JW; Vallelian F; Schaer CA; Puglia M; Buehler PW; Schaer DJ Free Radic Biol Med; 2015 Dec; 89():931-43. PubMed ID: 26475040 [TBL] [Abstract][Full Text] [Related]
37. What Is Next in This "Age" of Heme-Driven Pathology and Protection by Hemopexin? An Update and Links with Iron. Montecinos L; Eskew JD; Smith A Pharmaceuticals (Basel); 2019 Sep; 12(4):. PubMed ID: 31554244 [TBL] [Abstract][Full Text] [Related]
38. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free heme overload, NF-κB activation, and neutrophil infiltration. Dey S; Bindu S; Goyal M; Pal C; Alam A; Iqbal MS; Kumar R; Sarkar S; Bandyopadhyay U J Biol Chem; 2012 Aug; 287(32):26630-46. PubMed ID: 22696214 [TBL] [Abstract][Full Text] [Related]
39. [The Relevance of Hemolysis in Anesthesia and Intensive Care Medicine]. Graw JA; Baron DM; Francis RCE Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Apr; 53(4):296-305. PubMed ID: 29742788 [TBL] [Abstract][Full Text] [Related]
40. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. Camus SM; De Moraes JA; Bonnin P; Abbyad P; Le Jeune S; Lionnet F; Loufrani L; Grimaud L; Lambry JC; Charue D; Kiger L; Renard JM; Larroque C; Le Clésiau H; Tedgui A; Bruneval P; Barja-Fidalgo C; Alexandrou A; Tharaux PL; Boulanger CM; Blanc-Brude OP Blood; 2015 Jun; 125(24):3805-14. PubMed ID: 25827830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]